Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia

NCT02244658 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Antineoplastic Adverse Reaction
Thrombocytopenia
Acute Myelocytic Leukemia

Interventions

DRUG: rhTPO

Sponsor

Shandong University